LESLIE BRICE: Open Payments
NPI 1215325378 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,180 in 66 payments from 14 companies in 2025. Trend: 2023 $1,037 · 2024 $1,156 · 2025 $1,180
Food & beverage: $1,180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $277 |
| Novo Nordisk Inc | 17 | $253 |
| Lilly USA, LLC | 9 | $164 |
| AstraZeneca Pharmaceuticals LP | 8 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $99 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Amgen Inc. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Globus Medical, Inc. | 1 | $34 |
| Dexcom, Inc. | 1 | $30 |
Products named: QULIPTA, VRAYLAR, AIRSUPRA, TRINTELLIX, ZEPBOUND, Rybelsus, MOUNJARO, UBRELVY.
Industry payments across TX — which companies pay providers there.
